Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Prosthetic Arm Moves Like A Real Limb

By HospiMedica staff writers
Posted on 20 Feb 2007
A new technique called targeted muscle reinnervation allows a neuro-controlled prosthetic arm to move as if it is a real limb, reports a new study.

Researchers at the Rehabilitation Institute of Chicago (RIC; IL, USA) have developed the new technique that offers improved control of a motorized prosthetic arm. More...
They consequently conducted targeted reinnervation surgery on a 24-year old woman with a left arm amputation at the humeral neck. The reinnervation procedure allowed the re-routed nerves to grow into the appropriated muscle and direct the signals that they used to send to the amputated arm to the robotic arm (via surface electrodes) instead. This gave the patient better functional movement in her arm, and she reported using her neuro-controlled prosthesis for many hours a day.

Furthermore, using targeted sensory reinnervation, the sensation nerves to the hand were re-routed to a patch of skin on the patient's chest, so that when the patient is touched on this skin, she feels that her hand is being touched. This should eventually let her 'feel' what she is touching with an artificial hand, as if she were touching it with her own hand.
The results were published in the February 3, 2007, issue of The Lancet.

"This patient and our other three patients represent early application of the targeted reinnervation technique. Whether the improved function is enough to keep these patients wearing their devices in years to come, or whether they adapt to their new control even better and show greater functional gains, remains to be seen,” said Todd Kuiken, M.D., Ph.D., of the neural engineering center for artificial limbs, and colleagues. "Long-term follow-up is also needed to see how our patient's transfer sensation evolves.”

Targeted muscle reinnervation uses the residual nerves from an amputated limb and transfers them onto previously denervated alternative muscle groups. The muscles, newly reinnervated by a different group of nerves, then serve as biologic amplifiers of the amputated nerve motor commands.




Related Links:
Rehabilitation Institute of Chicago

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.